Abstract
In this study, twenty three 3,6-disubstituted 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives were synthesized and their antiproliferative activities in vitro were studied against SMMC-7721, HeLa, A549, and L929 by the CCK-8 assay. The bioassay results demonstrated that all tested compounds 8(a–w) exhibited antiproliferation with different degrees, and some compounds showed better effects than reference drug 5-fluorouracil. Among these screened compounds, compounds 8a, 8d, and 8l displayed significant antitumor activities in inhibiting SMMC-7721cell proliferation with IC50 values of 1.64, 1.74, and 1.61 µM, respectively. Compounds 8d and 8l were manifested highly effective biological activity versus HeLa cells with IC50 values of 2.23 and 2.84 µM, respectively. Compound 8l was found to have the highest antitumor potency against A549 cells with IC50 value of 2.67 µM. Furthermore, all compounds exhibited weaker cytotoxic effects than 5-fluorouracil on normal cell lines L929.
Similar content being viewed by others
References
Akhter MW, Hassan MZ, Amir M (2014) Synthesis and pharmacological evaluation of 3-diphenylmethyl-6-substituted-1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles: a condensed bridgehead nitrogen heterocyclic system. Arab J Chem 7:955–963
Alegaon SG, Parchure P, Araujo LD, Salve PS, Alagawadi KR, Jalalpure SS, Kumbaret VM (2017) Quinoline-azetidinone hybrids: synthesis and in vitro antiproliferation activity against Hep G2 and Hep 3B human cell lines. Bioorg Med Chem Lett 27:1566–1571
Almajan GL, Barbuceanu SF, Bancescu G, Saramet I, Saramet G, Draghici C (2010) Synthesis and antimicrobial evaluation of some fused heterocyclic [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives. Eur J Med Chem 45:6139–6146
Anand P, Kunnumakara AB, Sundaram C, Harikumar KB, Tharakan ST, Lai OS, Sung B, Aggarwal BB (2008) Cancer is a preventable disease that requires major lifestyle changes. Pharm Res 25:2097–2116
Banerjee AG, Das N, Shengule SA, Sharma PA, Srivastava RS, Shrivastava SK (2016) Design, synthesis, evaluation and molecular modelling studies of some novel 5,6-diphenyl-1,2,4-triazin-3(2H)-ones bearing five-member heterocyclic moieties as potential COX-2 inhibitors: a hybrid pharmacophore approach. Bioorg Chem 69:102–120
Bhatt P, Kumar M, Jha A (2018) Synthesis, docking and anticancer activity of azo-linked hybrids of 1,3,4-thia-/oxadiazoles with cyclic imides. Mol Divers 22:827–840
Branowska D, Ławecka J, Sobiczewski M, Karczmarzyk Z, Wysocki W, Wolińska E, Olender E, Mirosław B, Perzyna A, Bielawska A, Bielawski K (2018) Synthesis of unsymmetrical disulfanes bearing 1,2,4-triazine scaffold and their in vitro screening towards anti-breast cancer activity. Mon Chem 149:1409–1420
Cesarini S, Spallarossa A, Ranise A, Schenone S, Bruno O, Colla PL, Casula L, Collu G, Sanna G, Loddo R (2008) Parallel one-pot synthesis and structure–activity relationship study of symmetric formimidoester disulfides as a novel class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors. Bioorg Med Chem 16:6353–6363
Ceylan S (2016) Synthesis and biological evaluation of new Mannich and Schiff bases containing 1,2,4-triazole and 1,3,4-oxadiazole nucleus. Med Chem Res 25:1958–1970
Chelamalla R, Akena V, Manda S (2017) Synthesis of N′-arylidene-2-(5-aryl-1H-1, 2, 4-triazol- 3-ylthio)acetohydrazides as antidepressants. Med Chem Res 26:1359–1366
Chidananda N, Poojary B, Sumangala V, Kumari NS, Shetty P, Arulmoli T (2012) Facile synthesis, characterization and pharmacological activities of 3,6-disubstituted 1,2,4-triazolo[3,4-b][1,3,4] thiadiazoles and 5, 6-dihydro-3,6-disubstituted-1,2,4-triazolo[3,4-b][1,3,4]thiadiazoles. Eur J Med Chem 51:124–136
Chowrasia D, Karthikeyan C, Choure L, Sahabjada, Gupta M, Arshad M, Trivedi P (2017) Synthesis, characterization and anticancer activity of some fluorinated 3,6-diaryl-[1,2,4]triazolo[3,4-b][1,3, 4]thiadiazoles. Arab J Chem 10:S2424–S2428
Cui P, Li XL, Zhu MY, Wang BH, Liu J, Chen H (2017) Design, synthesis and antimicrobial activities of thiouracil derivatives containing triazolo-thiadiazole as SecA inhibitors. Eur J Med Chem 127:159–165
Deng XQ, Dong ZQ, Song MX, Shu B, Wang SB, Quan ZS (2012) Synthesis and anticonvulsant activities of some triazolothiadiazole derivatives. Arch Pharm Chem Life Sci 345:565–573
Er M, Ergüven B, Tahtaci H, Onaran A, Karakurt T, Ece A (2017) Synthesis, characterization, preliminary SAR and molecular docking study of some novel substituted imidazo[2,1-b][1,3,4]thiadiazole derivatives as antifungal agents. Med Chem Res 26:615–630
Eweiss NF, Bahajaj AA (1987) Synthesis of heterocycles. Part VII synthesis and antimicrobial activity of some 7H-s-triazolo[3,4-b][1,3,4] thiadiazine and s-triazolo[3,4-b] [1,3,4]thiadia-zole derivatives. J Heterocycl Chem 24:1173–1182
Harish KP, Mohana KN, Mallesha L (2014) Synthesis of new 2,5-disubstituted-1,3,4-thiadiazole derivatives and their in vivo anticonvulsant activity. Russ J Bioorg Chem 40:97–105
Hong S, Shin Y, Jung M, Ha MW, Park Y, Lee YJ, Shin J, Oh KB, Lee SK, Park HG (2015) Efficient synthesis and biological activity of Psammaplin A and its analogues as antitumor agents. Eur J Med Chem 96:218–230
Husain A, Shaharyar MRM, Siddiqui AA, Mishra R (2013) Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: new anticancer agents. Eur J Med Chem 62:785–798
Kahveci B, Menteşe E, Akkaya E, Yılmaz F, Doğan IS, Özel A (2014) Synthesis of some novel 1,2,4-triazol-3-one derivatives bearing the salicyl moiety and their anticonvulsant activities. Arch Pharm Chem Life Sci 347:449–455
Khan I, Tantray MA, Hamid H, Alam MS, Kalam A, Dhulap A (2016) Synthesis of benzimidazole based thiadiazole and carbohydrazide conjugates as glycogen synthase kinase-3b inhibitors with antidepressant activity. Bioorg Med Chem Lett 26:4020–4024
Li ZS, Wang WM, Lu W, Niu CW, Li YH, Li ZM, Wang JG (2013) Synthesis and biological evaluation of nonsymmetrical aromatic disulfides as novel inhibitors of acetohydroxyacid synthase. Bioorg Med Chem Lett 23:3723–3727
Li BC, Zhang DW, Zhang YM, Jiang D, Li S, Lei W, Wang HY, Lin F (2016) Synthesis and evaluation of novel benzene-ethanol bearing 1,2,4-triazole derivatives as potential antimicrobial agents. Med Chem Res 26:44–51
Liu DC, Gong GH, Wei CX, Jin XJ, Quan ZS (2016) Synthesis and anti-inflammatory activity evaluation of a novel series of 6-phenoxy-[1,2,4]triazolo[3,4-a]phthalazine-3-carboxamide derivatives. Bioorg Med Chem Lett 26:1576–1579
Menteşe E, Karaali N, Yılmaz F, Ülker S, Kahveci B (2013) Microwave-assisted synthesis and biological evaluation of some benzimidazole derivatives containing a 1,2,4-triazol ring. Arch Pharm Chem Life Sci 346:556–561
Meti GY, Kamble AA, Kamble RR, Somagond SM, Devarajegowda HC, Kumari S, Kalthur G, Adiga SK (2016) Synthesis, anti-proliferative and genotoxicity studies of 6-chloro-5-(2-substituted-ethyl)-1,3-dihydro-2H-indol-2-ones and 6-chloro-5-(2-chloroethyl)-3-(alkyl/ary-2-ylidene)indo-lin-2-ones. Eur J Med Chem 121:221–231
Miniyar PB, Mahajan AA, Mokale SN, Shah MU, Kumar AS, Chaturbhuj GU (2017) Triazole hybrids as new type of anti-fungal agents. Arab J Chem 10:295–299
Padmaja A, Pedamalakondaiah D, Sravya G, Reddy GM, Kumar MVJ (2015) Synthesis and antioxidant activity of a new class of sulfone/sulfonamide-linked bis(oxadiazoles), bis(thiadiazoles), and bis(triazoles). Med Chem Res 24:2011–2020
Roldán-Peňa JM, Alejandre-Ramos D, López Ó, Maya I, Lagunes I, Padrón JM, Peňa-Altamira LE, Bartolini M, Monti B, Bolognesi ML, Fernández-Bolaňos JG (2017) New tacrine dimers with antioxidant linkers as dual drugs: anti-Alzheimer’s and antiproliferative agents. Eur J Med Chem 138:761–773
Rostom SAF, Badr MH, El Razik HAA, Ashour HMA (2017) Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies. Eur J Med Chem 139:263–279
Rubino S, Busà R, Attanzio A, Alduina R, Stefano VD, Girasolo MA, Orecchio S, Tesoriere L (2017) Synthesis, properties, antitumor and antibacterial activity of new Pt(II) and Pd(II) complexes with 2,20-dithiobis(benzothiazole) ligand. Bioorg Med Chem 25:2378–2386
Shang J, Wang WM, Li YH, Song HB, Li ZM, Wang JG (2012) Synthesis, crystal structure, in vitro acetohydroxyacid synthase inhibition, in vivo herbicidal activity, and 3D-QSAR of new asymmetric aryl disulfides. J Agric Food Chem 60:8286–8293
Sheppard JG, Frazier KR, Saralkar P, Hossain MF, Geldenhuys WJ, Long TE (2018) Disulfiram-based disulfides as narrow-spectrum antibacterial agents. Bioorg Med Chem Lett 28:1298–1302
Sirakawa K, Aki O, Tsujikawa T (1970) S-alkylthioisothioureas. I. Chem Pharm Bull 18:235–242
Turos E, Revell KD, Ramaraju P, Gergeres DA, Greenhalgh K, Young A, Sathyanarayan N, Dickey S, Lim D, Alhamadsheh MM, Reynolds K (2008) Unsymmetric aryl-alkyl disulfide growth inhibitors of methicillinresistant staphylococcus aureus and bacillus anthracis. Bioorg Med Chem 16:6501–6508
Vale N, Ferreira A, Fernandes I, Alves C, Araújo MJ, Mateus N, Gomes P (2017) Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides. Bioorg Med Chem Lett 27:2898–2901
Vudhgiri S, Koude D, Veeragoni DK, Misra S, Prasad RBN, Jala RCR (2017) Synthesis and biological evaluation of 5-fatty-acylamido-1,3,4-thiadiazole-2-thioglycosides. Bioorg Med Chem Lett 27:3370–3373
Xu QL, Sun ML, Bai ZS, Wang YT, Wu Y, Tian HQ, Zuo DY, Guan Q, Bao K, Wu YL, Zhang WG (2017) Design, synthesis and bioevaluation of antitubulin agents carrying diaryl-5,5-fused-heterocycle scaffold. Eur J Med Chem 139:242–249
Xuan LN, Wang P, Zhang K, Shi YP, Liu YM, Zhu T, Chen BQ (2015) Synthesis and in vitro antiproliferative activity of novel benzisoselenazolone derivatives. Med Chem Res 24:543–552
Zhao PL, Chen P, Li Q, Hu MJ, Diao PC, Pan ES, You WW (2016) Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives. Bioorg Med Chem Lett 26:3679–3683
Acknowledgements
We are grateful to the Tianjin Municipal Natural Science Foundation (18JCYBJC94900) and Training Project of Innovation Team of Colleges and Universities in Tianjin (TD13-5020) for financial support.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary material
Rights and permissions
About this article
Cite this article
Liu, XJ., Liu, HY., Wang, HX. et al. Synthesis and antitumor evaluation of novel fused heterocyclic 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazole derivatives. Med Chem Res 28, 1718–1725 (2019). https://doi.org/10.1007/s00044-019-02409-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-019-02409-2